* Viveve Medical Inc VIVE.OQ reported a quarterly adjusted
loss of 67 cents per share for the quarter ended in September.
The mean expectation of two analysts for the quarter was for a
loss of 61 cents per share.
* Revenue rose 6% to $1.62 million from a year ago; analysts
expected $1.69 million.
* Viveve Medical Inc's reported EPS for the quarter was a loss
of 67 cents.
* The mean earnings estimate of analysts was unchanged in the
last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Viveve Medical Inc shares had fallen by 4.8% this quarter and
lost 53.8% so far this year.
* The company reported a quarterly loss of $7.05 million.
* Wall Street's median 12-month price target for Viveve Medical
Inc is $12.38
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated November 12 at 12:20 a.m.
All figures in US dollars unless otherwise stated